FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034983818> ?p ?o ?g. }

• W2034983818 endingPage "274" @default.
• W2034983818 startingPage "270" @default.
• W2034983818 abstract "Central serous chorioretinopathy (CSCR) is a poorly understood disease and the choroidal circulation abnormality induced by the plasminogen activator inhibitor type 1 (PAI-1) seems to be associated with the pathogenesis. There are many reports indicating that 4 G/5 G polymorphism of the PAI-1 gene is a risk factor for several diseases related to the elevated serum levels of PAI-1.To evaluate the 4 G/5 G polymorphism of the PAI-1 gene and its association with serum levels of PAI-1 in acute CSCR patients.Sixty CSCR patients and 50 healthy control patients were included. The PAI-1 4 G/5 G was genotyped using the polymerase chain reaction-restriction technique. Serum PAI-1 level was measured using enzyme-linked immunosorbent assay. Demographic data consisting of age, sex, body mass index (BMI) as well as genotype disturbances and serum PAI-1 levels were compared between the groups. Statistical significance for differences in the serum PAI-1 levels of each group with different genotypes was also analyzed.The CSCR group consisted of 40 male (66.7%) and 20 female (33.3%) patients with a mean age of 46.7 ± 8.39 years. The control group consisted of 32 male (64%) and 18 female (36%) healthy subjects with a mean age of 45.8 ± 8.39 years. There was no statistically significant difference between the groups in terms of age, sex and BMI. In the CSCR group the genotype frequencies were 4 G/4G: 30% (n = 18), 4G/5 G: 50% (n = 30), 5 G/5G: 20% (n = 12) and in the control group genotype frequencies were 34% (n = 17), 42% (n = 21) and 24% (n = 12), respectively. There was no statistically significant difference in the distribution of genotypes among the groups (chi-squared, p = 0.70). The CSCR group had a significantly higher serum PAI-1 concentration than the control group (p = 0.001). In both groups the mean plasma PAI-1 concentration did not vary significantly among the different genotypes (p > 0.05).Although our results demonstrated that the patients with acute CSCR have higher serum PAI-1 concentrations than the controls, no significant difference was found in the genotype disturbances of the PAI-1 gene between the groups. The current study indicates that 4 G/5 G polymorphism in the promoter of the PAI-1 gene cannot be considered a risk factor for the elevated serum PAI-1 levels and consequent development of CSCR." @default.
• W2034983818 created "2016-06-24" @default.
• W2034983818 creator A5032031219 @default.
• W2034983818 creator A5033242819 @default.
• W2034983818 creator A5034589821 @default.
• W2034983818 creator A5034920188 @default.
• W2034983818 creator A5043940377 @default.
• W2034983818 creator A5049032492 @default.
• W2034983818 creator A5066607918 @default.
• W2034983818 creator A5075223317 @default.
• W2034983818 creator A5083644195 @default.
• W2034983818 date "2014-01-22" @default.
• W2034983818 modified "2023-10-17" @default.
• W2034983818 title "The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (<i>PAI</i>-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels" @default.
• W2034983818 cites W14437416 @default.
• W2034983818 cites W1505365469 @default.
• W2034983818 cites W1965430426 @default.
• W2034983818 cites W1978237749 @default.
• W2034983818 cites W1995557286 @default.
• W2034983818 cites W1996375148 @default.
• W2034983818 cites W2011326884 @default.
• W2034983818 cites W2021282547 @default.
• W2034983818 cites W2034096990 @default.
• W2034983818 cites W2035928356 @default.
• W2034983818 cites W2046942052 @default.
• W2034983818 cites W2066113247 @default.
• W2034983818 cites W2066241299 @default.
• W2034983818 cites W2077333263 @default.
• W2034983818 cites W2080280470 @default.
• W2034983818 cites W2082527251 @default.
• W2034983818 cites W2121507070 @default.
• W2034983818 cites W2123079009 @default.
• W2034983818 cites W2123591247 @default.
• W2034983818 cites W2133394822 @default.
• W2034983818 cites W2135099241 @default.
• W2034983818 cites W2411331373 @default.
• W2034983818 cites W2415466662 @default.
• W2034983818 doi "https://doi.org/10.3109/15569527.2013.854372" @default.
• W2034983818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24446892" @default.
• W2034983818 hasPublicationYear "2014" @default.
• W2034983818 type Work @default.
• W2034983818 sameAs 2034983818 @default.
• W2034983818 citedByCount "18" @default.
• W2034983818 countsByYear W20349838182014 @default.
• W2034983818 countsByYear W20349838182015 @default.
• W2034983818 countsByYear W20349838182016 @default.
• W2034983818 countsByYear W20349838182017 @default.
• W2034983818 countsByYear W20349838182018 @default.
• W2034983818 countsByYear W20349838182019 @default.
• W2034983818 countsByYear W20349838182020 @default.
• W2034983818 countsByYear W20349838182021 @default.
• W2034983818 countsByYear W20349838182022 @default.
• W2034983818 countsByYear W20349838182023 @default.
• W2034983818 crossrefType "journal-article" @default.
• W2034983818 hasAuthorship W2034983818A5032031219 @default.
• W2034983818 hasAuthorship W2034983818A5033242819 @default.
• W2034983818 hasAuthorship W2034983818A5034589821 @default.
• W2034983818 hasAuthorship W2034983818A5034920188 @default.
• W2034983818 hasAuthorship W2034983818A5043940377 @default.
• W2034983818 hasAuthorship W2034983818A5049032492 @default.
• W2034983818 hasAuthorship W2034983818A5066607918 @default.
• W2034983818 hasAuthorship W2034983818A5075223317 @default.
• W2034983818 hasAuthorship W2034983818A5083644195 @default.
• W2034983818 hasConcept C104317684 @default.
• W2034983818 hasConcept C126322002 @default.
• W2034983818 hasConcept C134018914 @default.
• W2034983818 hasConcept C135763542 @default.
• W2034983818 hasConcept C146304588 @default.
• W2034983818 hasConcept C150173356 @default.
• W2034983818 hasConcept C2779679481 @default.
• W2034983818 hasConcept C2780221984 @default.
• W2034983818 hasConcept C2780675426 @default.
• W2034983818 hasConcept C2780942790 @default.
• W2034983818 hasConcept C54355233 @default.
• W2034983818 hasConcept C71924100 @default.
• W2034983818 hasConcept C76252995 @default.
• W2034983818 hasConcept C86803240 @default.
• W2034983818 hasConcept C90924648 @default.
• W2034983818 hasConceptScore W2034983818C104317684 @default.
• W2034983818 hasConceptScore W2034983818C126322002 @default.
• W2034983818 hasConceptScore W2034983818C134018914 @default.
• W2034983818 hasConceptScore W2034983818C135763542 @default.
• W2034983818 hasConceptScore W2034983818C146304588 @default.
• W2034983818 hasConceptScore W2034983818C150173356 @default.
• W2034983818 hasConceptScore W2034983818C2779679481 @default.
• W2034983818 hasConceptScore W2034983818C2780221984 @default.
• W2034983818 hasConceptScore W2034983818C2780675426 @default.
• W2034983818 hasConceptScore W2034983818C2780942790 @default.
• W2034983818 hasConceptScore W2034983818C54355233 @default.
• W2034983818 hasConceptScore W2034983818C71924100 @default.
• W2034983818 hasConceptScore W2034983818C76252995 @default.
• W2034983818 hasConceptScore W2034983818C86803240 @default.
• W2034983818 hasConceptScore W2034983818C90924648 @default.
• W2034983818 hasIssue "4" @default.
• W2034983818 hasLocation W20349838181 @default.
• W2034983818 hasLocation W20349838182 @default.
• W2034983818 hasOpenAccess W2034983818 @default.
• W2034983818 hasPrimaryLocation W20349838181 @default.

• next